• EAN/ESNR joint Webinar: Amyloid related imaging abnormalities (ARIA): from trial to clinical practice

    The webinar explores key figures in neuroradiology and the historical context of Alzheimer's disease, focusing on monoclonal antibodies and their treatment implications. It discusses the shift from symptom-based to biomarker-based diagnostics, the role of amyloid deposition, and the efficacy of agents like lecanemab and aducanumab. The session also addresses ARIA management, treatment protocols, and the importance of education for healthcare professionals.

    Meike Vernooij,Frederik Barkhof,Bogdan Draganski Speaker: Meike Vernooij,Frederik Barkhof,Bogdan Draganski

    FundamentalLevel: Fundamental

    Topics in this course:

    Alzheimer's Monoclonal Antibodies ARIA Management Neurodegenerative Biomarkers